ACTA1 and cancer: The fluorescence switch design ensures that cancer cells with a partial EMT program, once expressing αSMA, will remain tdTomato+/EGFP− even if/when they revert to epithelial morphology, possibly via mesenchymal‐to‐epithelial transition (MET).